Economist
0
What are the potential productivity impacts of new medications that treat Medicare beneficiaries? – Healthcare Economist
0

A key aspect of many medications is that they not only help people feel better, but often these medications can help them ...

0
Impact of genericization on drug prices and treatment value across 8 countries – Healthcare Economist
0

An interesting study of Miquel Serra-Burriel et al. (2024) It examines the impact of genericisation on drug prices in ...

0
Medicare Drug Price Negotiation leads to 38% to 79% price decrease – Healthcare Economist
0

Medicare drug price negotiation is here. Medicare's maximum fair prices (MFPs) result in discounts of between 38% and 79%. In fact, the actual discounts ...

0
Methods for Including Adverse Events in Economic Evaluations – Healthcare Economist
0

That's the title of a great review. Article by Salah Ghabri, Dalia Dawoud and Michael Drummond. This article notes that guidance on incorporating adverse ...

0
Should we extrapolate survival using ‘cure’ models? – Healthcare Economist
0

Clinical trials are short, but the benefits of many medicines last months or even years beyond the duration of these trials. To quantify the total costs ...

0
Health and wealth – Healthcare Economist
0

Are richer people healthier? If so, how strong is this relationship? Does it vary across countries? That's what an article says Kyriopoulos et al., 2024 ...

0
Has there been a decline in competition in the US? – Healthcare Economist
0

It is a difficult question to answer. Let us consider the following worldviews: Decline in competition. Competition has decreased because we see ...

0
What outcomes should we target to improve health outcomes and overall well-being? – Healthcare Economist
0

He Rippel Foundation has an interesting framework for describing the dimensions for improving individual health and ...

0
Why doctors don’t like insurance – Healthcare Economist
0

If you go to the doctor or dentist in the U.S., you can often get a discount if you pay out of pocket compared to paying ...

0
FTC report on PBMs – Healthcare Economist
0

Last week, the Federal Trade Commission (FTC) published a report titled “Pharmacy benefit managers: the powerful ...

Tools4BLS
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart